Skip to main content
. Author manuscript; available in PMC: 2015 Jun 16.
Published in final edited form as: Otolaryngol Head Neck Surg. 2014 Aug 4;151(4):612–618. doi: 10.1177/0194599814545083

Figure 2.

Figure 2

RACPP schematic showing (A) no tumor-contrast immediately post-injection; (B) high tumor-contrast following MMP-dependent cleavage, separating Cy5 from Cy7. (C) Application of RACPP to HNSCC specimens produces faster Cy5/Cy7 ratio change compared to normal tissue. Abbreviations: RACPP, ratiometric activatable cell-penetrating peptide; HNSCC, head and neck squamous cell carcinoma.